Current Medicinal Chemistry - Anti-Cancer Agents

Design of Selectively Activated Anticancer Prodrugs: Elimination and Cyclization Strategies
pp. 155-185(31)
Authors: Papot S.; Tranoy I.; Tillequin F.; Florent J.-C.; Gesson J.-P.

Porphyrins in Photodynamic Therapy - A Search for Ideal Photosensitizers
pp. 187-207(21)
Authors: Pushpan S.K.; Venkatraman S.; Anand V.G.; Sankar J.; Parmeswaran D.; Ganesan S.; Chandrashekar T.K.

Herbal Medicine in the Treatment of Cancer
pp. 209-214(6)
Authors: Ho J.W.; Leung Y.Kin; Chan C.Pong

Recent Developments in the Design, Synthesis and Structure-Activity Relationship Studies of Pyrrolo[2,1-c][1,4]benzodiazepines as DNA-Interactive Antitumour Antibiotics
pp. 215-254(40)
Authors: Kamal A.; Rao M.V.; Laxman N.; Ramesh G.; Reddy G.S.K.

Discovery of Antitumor Indolocarbazoles: Rebeccamycin, NSC 655649, and Fluoroindolocarbazoles
pp. 255-266(12)
Authors: Long B.H.; Rose W.C.; Vyas D.M.; Matson J.A.; Forenza S.

The Prodrugs of 5-Fluorouracil
pp. 267-310(44)
Authors: Malet-Martino M.; Jolimaitre P.; Martino R.

Protein-Protein Interactions: Lessons Learned
pp. 311-330(20)
Authors: Sharma S.K.; Ramsey T.M.; Bair K.W.